Skip to main content
SpringerLink
Log in

Drug interactions with SSRIs: although generally predictable, watch out for serotonin syndrome

  • Drug Reactions and Interactions
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Mitchell PB. Drug interactions of clinical significance with selective serotonin reuptake inhibitors. Drug Saf 1997 Dec; 17(6): 390–406

    Article  PubMed  CAS  Google Scholar 

  2. Sproule BA, Naranjo CA, Bremner KE, et al. Selective serotonin reuptake inhibitors and CNS drug interactions: a critical review of the evidence. Clin Pharmacokinet 1997 Dec: 33(6): 454–71

    Article  PubMed  CAS  Google Scholar 

  3. Rosenbaum JF. Managing selective serotonin reuptake inhibitor-drug interactions in clinical practice. Clin Pharmacokinet 1995; 29 (Suppl. 1): 53–9

    Article  PubMed  CAS  Google Scholar 

  4. Lynd L. Serotonin syndrome: the drug induced disease of the nineties. Can Pharm J 1997 Jul/Aug; 130: 31–4

    Google Scholar 

  5. Brcpsen K, Hansen MJG, Nielsen KK, et al. Inhibition by paroxetine of desipramine metabolism in extensive but not in poor metabolizers of sparteine. Ther Drug Monit 1993; 15: 173–4

    Google Scholar 

  6. DeMontigny CF, Ceurnoyer G, Morissette R. Lithium carbonate addition in tricyclic antidepressant-resistant unipolar depression. Arch Gen Psychiatry 1983; 40: 1327–34

    Article  PubMed  Google Scholar 

  7. Centorrino F, Baldessarini RJ, Frankenburg FR, et al. Serum levels of clozapine and norclozapine in patients treated with selected serotonin reuptake inhibitors. Am J Psychiatry 1996 Jun; 153: 820–2

    PubMed  CAS  Google Scholar 

  8. Bertschy G, Baumann P, Eap CB, et al. Probable metabolic interaction between methadone and fluvoxamine in addict patients. Ther Drug Monit 1994 Feb; 16: 42–5

    Article  PubMed  CAS  Google Scholar 

  9. Alderman CP, Hundertmark JD, Soetratma TW. Interaction of serotonin re-uptake inhibitors with perhexiline. Aust NZ J Psychiatry 1997 Aug; 31: 601–3

    Article  CAS  Google Scholar 

  10. British National Formulary. No. 35. London: The Pharmaceutical Press, 1998 Mar: 181–3, 554–8

  11. Sternbach H. The serotonin syndrome. Am J Psychiatry 1991; 148: 705–13

    PubMed  CAS  Google Scholar 

  12. Bhatara VS, Magnus RD, Paul KL. Serotonin syndrome induced by venlafaxine and fluoxetine: a case study in polypharmacy and potential pharmacodynamic and pharmacokinetic mechanisms. Ann Pharmacother 1998 Apr; 32: 432–6

    Article  PubMed  CAS  Google Scholar 

  13. Hawley CJ, Quick SJ, Ratnam S, et al. Safety and tolerability of combined treatment with moclobemide and SSRIs: a systemic study of 50 patients. Int Clin Psychopharmacol 1996 Sep; 11: 187–91

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Drug interactions with SSRIs: although generally predictable, watch out for serotonin syndrome. Drugs Ther. Perspect 12, 11–13 (1998). https://doi.org/10.2165/00042310-199812050-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199812050-00004

Search

Navigation